Diabetics that have been diagnosed with pancreatic cancer and families of diabetics that have died from pancreatic cancer are now filing lawsuits against drug manufacturers that intentionally hid pancreatic cancer risks and/or failed to warn of known pancreatic cancer risks. These lawsuits are seeking compensation from large drug manufacturers that made large profits by unlawfully selling dangerous diabetic drugs with known pancreatic cancer health risks. Persons who took diabetic drugs and families that have lost a loved one that took diabetic drugs and died of pancreatic cancer are encouraged to step forward and file lawsuits against these drug manufacturers that made billions of dollars from selling dangerous drugs.
If you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer or you have lost a loved one that was taking a diabetes drug and was diagnosed with pancreatic cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible. For persons that have been diagnosed with pancreatic cancer or families that have a loved one from pancreatic cancer, please feel free to send an e-mail message to Pancreatic Cancer Lawyer Jason Coomer or use our online form for a free case evaluation.
Diabetes drugs in the incretin mimetic class may cause an increased health risk of pancreatic cancer and pancreatitis. These incretin diabetes drug include exenatide (Byetta, Bydureon), liraglutide (Victoza), sitagliptin (Januvia, Janumet, Janumet XR, Juvisync), saxagliptin (Onglyza, Kombiglyze XR), alogliptin (Nesina, Kazano, Oseni), and linagliptin (Tradjenta, Jentadueto). These drugs work by mimicking the incretin hormones that the body usually produces naturally to stimulate the release of insulin in response to a meal. They are used along with diet and exercise to lower blood sugar in adults with type 2 diabetes. Many of these incretin diabetes drugs already include a black box warning regarding thyroid cancer risk, but evidence is growing that these drugs may also create an increased risk of pancreatic cancer.
People that are taking incretin diabetes drugs including: Januvia, Janument, Victoza, Byetta, Onglyza, Tradjenta, Oseni, and other diabetes drugs should be aware of the cancer health risks. If you have been taking a diabetes drug and have been diagnosed with Pancreatic Cancer or you have lost a loved one that was taking a diabetes drug and was diagnosed with pancreatic cancer, please report the adverse action to the prescribing medical doctor and FDA as soon as possible.
Pancreatic cancer is the fourth leading cause of cancer death for both men and women and is one of the most deadly of all types of cancer. This year approximately 45,000 Americans will be diagnosed with pancreatic cancer and about 38,000 will die from it. One of the reasons that pancreatic cancer is so deadly is that it it difficult to diagnose and the diagnosis is often made late in the course of the disease. Early detection of pancreatic cancer is essential and will greatly improve a person's chances of surviving the disease. As such, people that have taken diabetes drugs, especially those with symptoms of weight loss, dark urine and clay-colored stools, back pain, and jaundice, should seek advice from a qualified medical professional as to if they may have pancreatic cancer and what symptoms they should be aware of to detect any early onset of pancreatic cancer.
The most common kind of pancreatic cancer is pancreatic adenocarcinoma and includes about 90% of the cases of pancreatic cancer. Pancreatic adenocarcinoma is a cancerous overgrowth of exocrine pancreatic cells and is unfortunately commonly undetected until it is too late for the patient. Pancreatic adenocarcinoma because of late detection can often result a fatal diagnosis with very limited survival time. Other forms of exocrine pancreas cancer include: intraductal papillary mucinous neoplasm (IPMN), adenosquamous carcinomas, acinar cell carcinomas, mucinous cystadenocarcinomas, signet ring cell carcinomas, hepatoid carcinomas, colloid carcinomas, undifferentiated carcinomas, pancreatoblastomas, and undifferentiated carcinomas with osteoclast-like giant cells.
Symptoms of pancreatic cancer can include: dark urine and clay-colored stools, fatigue and weakness, jaundice (a yellow color in the skin, mucus membranes, or eyes), loss of appetite and weight loss, nausea and vomiting, pain or discomfort in the upper part of the belly or abdomen, back pain, blood clots, diarrhea, and indigestion.
Pancreatic cancer is often not detected early on and is often advanced when it is first found. As such, ninety-five percent of the people diagnosed with this cancer will not be alive 5 years later. Some patients have pancreatic cancer that can be surgically removed are cured. However, in more than 80% of patients the tumor has already spread and cannot be completely removed at the time of diagnosis. In the few cases where pancreatic tumors can be removed by surgery. The standard surgical procedure to remove pancreatic tumors is called a Whipple procedure (pancreatoduodenectomy or pancreaticoduodenectomy). This surgery should be done by an experienced surgeon and at a medical center that performs the procedure often. Some studies suggest that the Whipple procedure is best performed at hospitals that do more than five of these surgeries per year.
When the tumor has not spread out of the pancreas, but cannot be removed, radiation therapy and chemotherapy together may be recommended. When the tumor has spread (metastasized) to other organs such as the liver, chemotherapy alone is usually used. The standard chemotherapy drug is gemcitabine, but other drugs may be used. Gemcitabine can help about 25% of patients.
Patients whose tumor cannot be totally removed, but who have a blockage of the tubes that transport bile (biliary obstruction) must have that blockage relieved. There are two approaches including surgery and placement of a tiny metal tube (biliary stent) during ERCP.
Managing pain and other symptoms is an important part of treating advanced pancreatic cancer. Palliative care tams and hospice can help with pain and symptom management, and provide psychological support for patients and their families during the illness.
More than 300 million people worldwide suffer from diabetes, including about 30 million Americans. In 2010, the global prevalence of diabetes was estimated to have reached 285 million and predicted to reach 438 million by 2030. The corresponding figures for North America were 37.4 million in 2010 and 53.2 million by 2030 and in Europe 55.2 million in 2010 and 66.2 million in 2030. The global market for products in the management of diabetes currently stands at $41 billion and is on pace to grow to over $114 billion by 2018.
The diabetes drugs, Januvia and Janumet, may cause an increased risk of pancreatic cancer in patients using Januvia. If you have lost a loved one from Pancreatic Cancer, please report the adverse action to the prescribing medical doctor as soon as possible. As an Januvia Cancer Death Lawyer, Jason S. Coomer, helps families that have lost a family member from cancer including pancreatic cancer. For more information on this topic, please go to the following web page on Januvia Pancreatic Cancer Lawsuits and Janumet Pancreatic Cancer Lawsuits.
The injectable diabetes drug, Byetta, may cause an increased risk of pancreatic cancer in patients. If you have lost a loved one from Pancreatic Cancer, please report the adverse action to the prescribing medical doctor as soon as possible. As a Byetta Pancreatic Cancer Lawyer, Jason S. Coomer, helps people that have suffered from defective drugs and families that have lost a family member from cancer including pancreatic cancer. For more information on this topic, please go to the following web page on Byetta Pancreatic Cancer Lawsuits and Exenatide Pancreatic Cancer Lawsuits.
The consumer group, Public Citizen, has filed a petition with the Food and Drug Administration (FDA) requesting that the agency immediately remove the diabetes drug, Victoza, from the market the increasingly prescribed diabetes drug Victoza (liraglutide [rDNA origin] injection) because it puts patients at higher risk of thyroid cancer, pancreatitis, serious allergic reactions and kidney failure that outweigh any documented clinical benefits. Public Citizen claims that the diabetes drug, Victoza, has a number of possible side effects including pancreatic cancer. This side effect is extremely dangerous, because once a person has pancreatic cancer and that cancer spreads, a patient stands just a 1.8% chance of surviving for longer than five years.
If you have lost a loved one from Pancreatic Cancer or have suffered acute pancreatitis, hemorrhagic pancreatitis, accute necrotizing pancreatitis, or pancreas cancer; and have been using Victoza or another diabetes drug, please report the adverse action to the prescribing medical doctor as soon as possible. For more Victoza Pancreatic Cancer Lawsuit, Victoza Cancer Death Lawsuit, or Diabetes Drug Pancreas Cancer Lawsuit information, please feel free to contact Victoza Pancreatic Cancer Lawyer, Victoza Diabetes Drug Cancer Lawyer, and Victoza Pancreas Cancer Death Lawyer Jason Coomer a Texas lawyer, or use our online submission form.
For more information on this topic, please go to the following web page on Victoza Pancreatic Cancer Lawsuits and Victoza Cancer Death Lawsuits.
Texas Dangerous Drug Attorney Jason Coomer commonly works with other lawyers throughout Texas, the United States, and the World including Houston Pancreatic Cancer Lawyers, San Antonio Pancreatic Cancer Lawyers, Dallas Pancreatic Cancer Lawyers, New York Diabetes Drug Pancreatic Cancer Lawyers, Chicago Diabetes Drug Pancreatic Cancer Lawyers, and other Texas Pancreatic Cancer Death Lawyers. By sharing information and working together, his law firm and other firms throughout World are able to provide better representation for their clients.
If you have lost a loved one from Pancreatic Cancer or have suffered acute pancreatitis, hemorrhagic pancreatitis, accute necrotizing pancreatitis, or pancreas cancer; and have been using a diabetes drug, please report the adverse action to the prescribing medical doctor as soon as possible. For more information on this topic, please feel free to contact Pancreatic Cancer Lawyer, Pancreatic Adenocarcinoma Lawyer, and Pancreas Cancer Lawyer Jason Coomer a Texas lawyer, or use our online submission form.